MJNA

HempMeds is a subsidiary of Medical Marijuana, Inc. (MJNA), a publicly traded company that sells a variety of cannabis-based products in the United States and abroad. MJNA has made international headlines with its recent status as an exclusive importer of cannabidiol oil products to Brazil. In February of 2017, the Brazilian government approved a prescription for HempMeds’ Real Scientific Hemp Oil as a treatment for multiple sclerosis. Multiple sclerosis is a debilitating disease that affects the central nervous system, causing pain and a variety of other neuromuscular issues. With Real Scientific Hemp Oil, patients can experience the life-changing benefits of cannabidiol oil without the harmful side effects that accompany most pain medications.

The 2017 decision made by the Brazilian government’s National Health Surveillance Agency (ANVISA) is the first import approved for RSHO as a treatment for multiple sclerosis. More than 2.5 million people suffer from multiple sclerosis worldwide, which means that HempMeds is only beginning to tap into the existing market potential for these innovative and safe products. Many people with multiple sclerosis face a lack of treatment options or a choice between living with untreated symptoms and the unpleasant side effects of other drugs. RSHO’s products offer powerful relief without the potential for addiction or many of the other side effects that accompany other pharmaceuticals.

Cannabis Products Worldwide

The 2016 United States elections resulted in the expanded legalization of both recreational and medical marijuana products. As a result, the market for the products HempMeds offers is greater than ever. Because cannabidiol oil offers relief for medical symptoms such as pain, seizures and tremors without producing the psychotropic effects associated with marijuana, it is an ideal treatment option for many younger patients worldwide. International and domestic case studies demonstrate the effectiveness of RSHO’s product line in the treatment of seizures, and MJNA’s recent clinical trials have provided even more support for the effectiveness of cannabidiol oil.

Cannabidiol as a Treatment for Alzheimer’s Disease

In addition to being used as a treatment for multiple sclerosis, ANVISA has also recently approved these products as a treatment for Alzheimer’s. Alzheimer’s disease treatment is the next frontier for MJNA’s revolutionary line of cannabis-based products. More than 46.8 million people worldwide suffer from Alzheimer’s, a debilitating and ultimately fatal condition that greatly affects cognitive functions, such as memory. According to Medical Marijuana, Inc. CEO, Dr. Stuart Titus, there is a “vital need” for the company’s products when it comes to treating the symptoms of Alzheimer’s. Real Scientific Hemp Oil shows promise in the treatment of various Alzheimer’s-related symptoms. One recent research study conducted by Stanford University found that Alzheimer’s may be caused by Endogenous Cannabinoid Deficiency. Endocannabinoids are naturally found in the brain, and their blockage is associated with the early onset of Alzheimer’s.

These findings could be revolutionary when it comes to expanding treatment options for Alzheimer’s patients. Until recently, many aspects of the disease and its progression have remained unknown. RSHO’s products are already known to be effective in the treatment of epilepsy and Parkinson’s disease, and future research could confirm the potential for effectiveness in a variety of other neurological conditions as well.

RSHO Now Approved to Treat Autism Spectrum Disorder (ASD) in Brazil

HempMeds® Brasil, recently announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).

This marks the first time Brazil’s National Health Surveillance Agency ANVISA has granted the prescription for RSHO™ to help an Autism patient. Earlier this month, ANVISA granted the filling of two separate prescriptions for RSHO™ for the first time to help patient combat the effects of Multiple Sclerosis and Alzheimer’s disease.

ASD is a neurodevelopment disorder that develops in infancy or childhood and is characterized by social interaction difficulties, verbal and physical communication impairments, and restricted and repetitive patterns of behavior. According to the Centers for Disease Control and Prevention, 1 in 68 children in the U.S. currently have ASD. In Brazil, recent statistics suggest that 1.5 million total children have autism.

The Outlook for HempMeds

As permissions for cannabidiol oils continue to expand worldwide, HempMeds and Medical Marijuana, Inc. are at the forefront of cannabis product research and development. The versatility of these products works in combination with a tightly controlled formulation process to create treatment options that are not only safe but effective. Patients with conditions such as multiple sclerosis and Parkinson’s disease face a shortage of options in the traditional pharmaceutical market. As doctors worldwide continue to see the benefits of RSHO’s products in a variety of treatment settings, the company will be able to expand its reach.

2017 has already been a year of success for MJNA and its subsidiary companies, and that trend promises to continue. Between many different case studies, clinical trials and wide-reaching news coverage, the company’s name is spreading fast. Attached to that name is the consumer confidence that comes with scientifically formulated products that are designed with reliability and accessibility in mind.

About the Author

Stuart Smith is the CEO and Founder of SmallCapVoice.com. SmallCapVoice.com. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/